For instance, approximately 30% of breast cancers are associated with activating missense mutations of PIK3CA, the gene encoding the catalytic p110α subunit of class IA PI3K, which provides cells with a growth advantage and promotes tumor progression [13]. This evidence concerns the gene PIK3CD and breast carcinoma.